"

Sitagliptin (486460-32-6), a new hypoglycemic agents dipeptidyl peptidase -4 (DPP-4) inhibitor, can improve the body's own ability to reduce excessively high blood sugar levels.

This enzyme-inhibiting drug is used either alone or in combination with other oral antihyperglycemic agents (such as metformin or athiazolidinedione) for treatment of diabetes mellitus type 2

The benefit of this medicine is its fewer side effects (e.g., less hypoglycemia, less weight gain) in the control of blood glucose values.

Methyl 3-oxo-4-(2,4,5-trifluorophenyl)butanoate (769195-26-8) is a key intermediate used for Sitagliptin (486460-32-6) . the minimum order quantity is 500 g. Packing size : 500g/bag, 1000g/bag, 10kg/bag. 25kg/bag. 

"